![](/img/cover-not-exists.png)
Development of high-specific-activity 68Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors
Melchor V. Cantorias, Said D. Figueroa, Thomas P. Quinn, John R. Lever, Timothy J. Hoffman, Lisa D. Watkinson, Terry L. Carmack, Cathy S. CutlerVolume:
36
Year:
2009
Language:
english
DOI:
10.1016/j.nucmedbio.2009.01.017
File:
PDF, 524 KB
english, 2009